Your browser doesn't support javascript.
loading
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50.
Gainor, J F; Rizvi, H; Jimenez Aguilar, E; Skoulidis, F; Yeap, B Y; Naidoo, J; Khosrowjerdi, S; Mooradian, M; Lydon, C; Illei, P; Zhang, J; Peterson, R; Ricciuti, B; Nishino, M; Zhang, J; Roth, J A; Grishman, J; Anderson, D; Little, B P; Carter, B W; Arbour, K; Sauter, J L; Mino-Kenudson, M; Heymach, J V; Digumarthy, S; Shaw, A T; Awad, M M; Hellmann, M D.
Afiliación
  • Gainor JF; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA. Electronic address: jgainor@partners.org.
  • Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Jimenez Aguilar E; Lowe Center for Thoracic Oncology, Department of Medical Oncology and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Skoulidis F; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Yeap BY; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Naidoo J; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Khosrowjerdi S; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Mooradian M; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Lydon C; Lowe Center for Thoracic Oncology, Department of Medical Oncology and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Illei P; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Zhang J; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Peterson R; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Ricciuti B; Lowe Center for Thoracic Oncology, Department of Medical Oncology and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Nishino M; Lowe Center for Thoracic Oncology, Department of Medical Oncology and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Zhang J; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Roth JA; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Grishman J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Anderson D; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Little BP; Department of Radiology, Massachusetts General Hospital, Boston, USA.
  • Carter BW; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Arbour K; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
  • Sauter JL; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, USA.
  • Heymach JV; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Digumarthy S; Department of Radiology, Massachusetts General Hospital, Boston, USA.
  • Shaw AT; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Awad MM; Lowe Center for Thoracic Oncology, Department of Medical Oncology and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Ann Oncol ; 31(3): 404-411, 2020 03.
Article en En | MEDLINE | ID: mdl-32067682
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfolipasa D / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfolipasa D / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article